Obesity or abnormal weight gain is a global health issue for a greater proportion of the population because it advances to many other severe diseases such as diabetes, and PCOD (Polycystic Ovarian ...

Treating Mechanism. Minoxidil is external – scalp based treatment, used for all types of hair loss including androgenic alopecia. Finasteride is both Pill and topical application, and works only on ...

Causes of Erectile Dysfunction. ED can result from a complex interplay of physical and psychological factors. Common causes include: Cardiovascular Diseases: Conditions like hypertension, ...

Hair loss is a prevalent concern affecting a significant portion of the population. Studies indicate that approximately 60% of men will experience hair loss at some point in their lives, with over ...

Women often experience migraines due to hormonal changes that occur at various stages of life, with estrogen dips before menstruation being a common trigger. These fluctuations can significantly ...

So A and B both got diagnosed with male pattern balding. It starts thinning hair from the crown area and a receding hairline, and is probably inherited. Both get a prescription for Finasteride pills ...

Well, strictly speaking it is not so much topical finasteride versus finasteride pills, but really a combination of the two which effectively prevents hair loss due to male pattern baldness.

5α-reductase, the enzyme responsible for converting testosterone to dihydrotestosterone, exists in 2 forms: Type 1 and Type 2. Finasteride selectively inhibits Type 2 whereas dutasteride inhibits both ...

Menopause refers to the retrospective cessation of menstrual cycles in women. Menopause leads to vasomotor, psychological, and genito-urinary symptoms, and cognitive inefficiencies among patients.

Polycystic ovary syndrome, also known as PCOS, is a hormonal condition that affects women who are of reproductive age (1). Weight gain, especially around the midsection, is one of the typical symptoms ...

A study published by Dove Medical Press discusses transdermal testosterone therapy in men and says that “most men (age 22 to 69 years) prefer a topical gel product over an injection or patch due to ...